These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 14610345

  • 1. Morphological features of rat gastric mucosa after acute and chronic treatment with amtolmetin guacyl: comparison with non-selective and COX-2-selective NSAIDs.
    Morini G, Guaita E, Lazzaretti M, Grandi D, Coruzzi G.
    Digestion; 2003; 68(2-3):124-32. PubMed ID: 14610345
    [Abstract] [Full Text] [Related]

  • 2. Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase.
    Coruzzi G, Coppelli G, Spaggiari S, Cavestro GM, Okolicsanyi L, Lo Giudice P, Pisano C, Tepperman BL.
    Dig Liver Dis; 2002 Jun; 34(6):403-10. PubMed ID: 12132787
    [Abstract] [Full Text] [Related]

  • 3. Gastrosparing effect of new antiinflammatory drug amtolmetin guacyl in the rat: involvement of nitric oxide.
    Pisano C, Grandi D, Morini G, Coppelli G, Vesci L, Lo Giudice P, Pace S, Pacifici L, Longo A, Coruzzi G, Carminati P.
    Dig Dis Sci; 1999 Apr; 44(4):713-24. PubMed ID: 10219827
    [Abstract] [Full Text] [Related]

  • 4. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.
    Kirkova M, Alexandova A, Kesiova M, Todorov S.
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):99-104. PubMed ID: 17391279
    [Abstract] [Full Text] [Related]

  • 5. Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.
    Tubaro E, Belogi L, Mezzadri CM, Ruco L, Stopacciaro A.
    Arzneimittelforschung; 1995 Dec; 45(12):1298-302. PubMed ID: 8595088
    [Abstract] [Full Text] [Related]

  • 6. Gastroprotective effect and mechanism of amtolmetin guacyl in mice.
    Li YH, Li J, Huang Y, Lu XW, Jin Y.
    World J Gastroenterol; 2004 Dec 15; 10(24):3616-20. PubMed ID: 15534917
    [Abstract] [Full Text] [Related]

  • 7. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.
    Jajić Z, Malaise M, Nekam K, Koó E, Dankó K, Kovacs M, Scarpignato C.
    Clin Exp Rheumatol; 2005 Dec 15; 23(6):809-18. PubMed ID: 16396699
    [Abstract] [Full Text] [Related]

  • 8. Potential antioxidant activity of celecoxib and amtolmetin guacyl: in vitro studies.
    Kirkova M, Alexandova A, Kesiova M, Tsvetanova E, Georgieva A, Todorov S.
    Auton Autacoid Pharmacol; 2007 Jan 15; 27(1):13-8. PubMed ID: 17199871
    [Abstract] [Full Text] [Related]

  • 9. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury.
    Kirkova M, Kesiova M, Konstantinova S, Alexandrova A, Petrov L, Tsvetanova E, Todorov S.
    Auton Autacoid Pharmacol; 2007 Jan 15; 27(1):63-70. PubMed ID: 17199877
    [Abstract] [Full Text] [Related]

  • 10. Selective cyclooxygenase (COX) inhibition causes damage to portal hypertensive gastric mucosa: roles of nitric oxide and NF-kappaB.
    Akahoshi T, Tanigawa T, Sarfeh IJ, Chiou SK, Hashizume M, Maehara Y, Jones MK.
    FASEB J; 2005 Jul 15; 19(9):1163-5. PubMed ID: 15845610
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of amtolmetin guacyl versus placebo diclofenac and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage.
    Riezzo G, Chiloiro M, Montanaro S.
    Dig Dis Sci; 2001 Aug 15; 46(8):1797-804. PubMed ID: 11508686
    [Abstract] [Full Text] [Related]

  • 12. The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM.
    Eur J Pharmacol; 2000 Jan 10; 387(2):233-44. PubMed ID: 10650165
    [Abstract] [Full Text] [Related]

  • 13. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G, Montrone F, Lazzaroni M, Manzionna G, Caruso I.
    Ital J Gastroenterol Hepatol; 1999 Jan 10; 31(5):378-85. PubMed ID: 10470596
    [Abstract] [Full Text] [Related]

  • 14. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
    Lazzaroni M, Anderloni A, Bianchi Porro G.
    Eur J Gastroenterol Hepatol; 2001 Jul 10; 13(7):833-9. PubMed ID: 11474314
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M, Pajdo R, Kwiecien S, Ptak-Belowska A, Sliwowski Z, Mazurkiewicz-Janik M, Konturek SJ, Pawlik WW, Brzozowski T.
    J Physiol Pharmacol; 2011 Feb 10; 62(1):75-86. PubMed ID: 21451212
    [Abstract] [Full Text] [Related]

  • 16. Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM.
    Arzneimittelforschung; 2001 Sep 10; 51(9):737-42. PubMed ID: 11642006
    [Abstract] [Full Text] [Related]

  • 17. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
    Menozzi A, Pozzoli C, Giovannini E, Solenghi E, Grandi D, Bonardi S, Bertini S, Vasina V, Coruzzi G.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):143-50. PubMed ID: 17069793
    [Abstract] [Full Text] [Related]

  • 18. Gastric effects of the selective cyclooxygenase-2 inhibitor, celecoxib, in the rat.
    Coppelli G, Guaita E, Spaggiari S, Coruzzi G.
    Dig Liver Dis; 2004 Apr 15; 36(4):265-70. PubMed ID: 15115339
    [Abstract] [Full Text] [Related]

  • 19. Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
    Fomenko I, Sklyarov A, Bondarchuk T, Biletska L, Panasyuk N, Wallace JL.
    Stress; 2014 Dec 15; 17(6):528-37. PubMed ID: 25238023
    [Abstract] [Full Text] [Related]

  • 20. Gastroprotective and safety effects of WIN-34B, a novel treatment for osteoarthritis, compared to NSAIDs.
    Huh JE, Lee WI, Seo BK, Baek YH, Lee JD, Choi DY, Park DS.
    J Ethnopharmacol; 2011 Sep 02; 137(2):1011-7. PubMed ID: 21782922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.